<DOC>
	<DOCNO>NCT01381718</DOCNO>
	<brief_summary>RATIONALE : Modafinil may help improve memory , attention , fatigue cause cancer treatment . PURPOSE : This phase II randomize trial study well modafinil work treat child memory attention problem cause cancer treatment brain tumor .</brief_summary>
	<brief_title>Modafinil Treating Children With Memory Attention Problems Caused Cancer Treatment Brain Tumor</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine whether 6-week drug trial modafinil , compare placebo , associate improvement neurocognitive function define direct assessment attention child cognitive impairment treatment primary brain tumor . Secondary - Determine whether modafinil , compare placebo , associate improved executive function , assess use BRIEF executive function hippocampal learn executive function task CogState battery . Determine whether modafinil , compare placebo , associate improved attention , assess Conners ' ( 3rd Edition ) 3 Parent Rating Scale ( CPRS-3 ) - Short Form . - Determine whether modafinil , compare placebo , associate reduce fatigue assess use PedsQL Multidimensional Fatigue Scale . - Evaluate safety modafinil population . OUTLINE : This multicenter study . Participants randomize 1 2 treatment arm . - Arm I : Participants receive modafinil orally ( PO ) daily ( QD ) day 1-42 . - Arm II : Participants receive placebo PO QD day 1-42 . Participants complete semi-automated , computerize cognitive-testing system ( CogState ) design assess psychomotor , attention/vigilance , memory , component executive function present different task , set rule , baseline completion study therapy . Participants also complete PedsQL Multidimensional Fatigue Scale ( Peds QL-MFS ) . Parents legal guardian complete PedsQL-MFS , Conners Parent Reported Scale ( CPR-3 ) , Behavior Rating Inventory Executive Function ( BRIEF ) baseline completion study therapy . Clinical and/or research staff administer Systematic Assessment Treatment Emergency Events ( SAFTEE ) , semi-structured interview design elicit adverse event , baseline periodically study . After completion study therapy , participant follow 30 day .</detailed_description>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Neurotoxicity Syndromes</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<criteria>INCLUSION CRITERIA : Age ≥ 6 year ≤ 18 year 10 month time study entry ( participant &lt; 19 6 week evaluation , upper age limit include instrument valid ) . Diagnosis primary brain tumor treat least one following : 1. neurosurgical resection brain tumor ; 2. cranial irradiation ; 3. chemotherapy treat brain tumor . Offtreatment progressionfree least 12 month ≤ 14 year . Treatment cessation define final dose chemotherapy , last dose ( fraction ) radiation date surgery , whichever occur last . Parent/Legal Guardian child able read English Spanish . Vision hearing ( eyeglasses and/or hearing aid permissible ) sufficient valid test administration cooperation examination . Availability reliable parent legal guardian willing able complete outcome measure fulfill requirement study , include administration medication accompany participant study visit . Females childbearing potential must negative pregnancy test result must agree use medically acceptable method contraception throughout entire study period 30 day last dose study drug . Childbearing potential defined girl &gt; Tanner stage 2 , except document pan pituitary insufficiency hormonal state incompatible pregnancy . Urine pregnancy test acceptable . EXCLUSION CRITERIA : Off treatment &gt; 14 year Inability perform test procedure ( example , aphasia , motor deficit affect dominant hand , IQ &lt; 70 ) Known cardiac disorder include arrhythmia , hypertension require treatment structural heart disease Diagnosis narcolepsy , sick sinus syndrome , arrhythmia prolonged QTc History stroke head injury associate loss consciousness within 12 month registration History grade 2 depression anxiety treatment antidepressant , antipsychotic MAO inhibitor within 30 day registration Concurrent treatment medication substance potent inhibitor inducer CYP3A4 , hepatic enzyme induce antiepileptic drug ( EIAEDs ) , drug know affect metabolism modafinil . Examples include limited itraconazole , ketoconazole , doxycycline , rifampin , St. John 's wort , phenytoin , phenobarbital , diazepam , tricyclic antidepressant . If patient previously take , EIAEDs , must &gt; 2 week prior study enrollment . Treatment stimulant medication within 14 day registration ; however , diagnosis ADHD NOT exclude child participation Participants know hypersensitivity modafinil , armodafinil component</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>childhood brain tumor</keyword>
	<keyword>neurotoxicity</keyword>
	<keyword>fatigue</keyword>
	<keyword>cognitive/functional effect</keyword>
	<keyword>psychosocial effect cancer treatment</keyword>
</DOC>